Literature DB >> 7739021

Free secretory component and lactoferrin of human milk inhibit the adhesion of enterotoxigenic Escherichia coli.

L G Giugliano1, S T Ribeiro, M H Vainstein, C J Ulhoa.   

Abstract

The non-immunoglobulin component of human milk responsible for the inhibition of Escherichia coli cell adhesion (haemagglutination) mediated by colonisation factor antigen 1 (CFA1) was determined by chromatographic fractionation of human whey proteins with Sephadex G-200, DEAE cellulose and heparin-sepharose. Pure free secretory component (fSC) and pure lactoferrin (Lf) were isolated and both compounds inhibited the haemagglutination induced by E. coli CFA1+. The lowest concentrations of purified fSC and Lf able to inhibit the haemagglutination induced by E. coli strain TR50/3 CFA1+ were 0.06 mg/ml and 0.1 mg/ml respectively. Commercially available lactoferrin from human milk and transferrin from human serum, which has a great structural analogy to lactoferrin, also inhibited the haemagglutination. The lowest concentrations of the commercial lactoferrin and transferrin able to inhibit the haemagglutination induced by E. coli TR50/3 CFA1+ were 0.03 mg/ml and 0.4 mg/ml, respectively. These results indicate that fSC and Lf may be important non-specific defence factors against enterotoxigenic E. coli infections.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7739021     DOI: 10.1099/00222615-42-1-3

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  23 in total

1.  Expression, purification and biochemical characterization of recombinant murine secretory component: a novel tool in mucosal immunology.

Authors:  P Crottet; S Cottet; B Corthésy
Journal:  Biochem J       Date:  1999-07-15       Impact factor: 3.857

2.  Multiple cleavage sites for polymeric immunoglobulin receptor.

Authors:  Masatake Asano; Nobuko Takenouchi-Ohkubo; Naoyuki Matsumoto; Yoshitaka Ogura; Hirofumi Nomura; Hisashi Suguro; Itaru Moro
Journal:  Immunology       Date:  2004-08       Impact factor: 7.397

3.  Porcine and Bovine Forms of Lactoferrin Inhibit Growth of Porcine Enterotoxigenic Escherichia coli and Degrade Its Virulence Factors.

Authors:  Bert Devriendt; Eric Cox; Matthias Dierick; Hans Van der Weken; Joanna Rybarczyk; Daisy Vanrompay
Journal:  Appl Environ Microbiol       Date:  2020-11-24       Impact factor: 4.792

4.  Expression of full-length bioactive antimicrobial human lactoferrin in potato plants.

Authors:  D K Chong; W H Langridge
Journal:  Transgenic Res       Date:  2000-02       Impact factor: 2.788

Review 5.  Immunogenicity and efficacy of oral vaccines in developing countries: lessons from a live cholera vaccine.

Authors:  Myron M Levine
Journal:  BMC Biol       Date:  2010-10-04       Impact factor: 7.431

6.  Retinoic acid enhances the gene expression of human polymeric immunoglobulin receptor (pIgR) by TNF-alpha.

Authors:  N Takenouchi-Ohkubo; M Asano; H Chihaya; W U Chung-Hsuing; K Ishikasa; I Moro
Journal:  Clin Exp Immunol       Date:  2004-03       Impact factor: 4.330

7.  Polymeric immunoglobulin receptor traffics through two distinct apically targeted pathways in primary lacrimal gland acinar cells.

Authors:  Shi Xu; Linlin Ma; Eunbyul Evans; Curtis T Okamoto; Sarah F Hamm-Alvarez
Journal:  J Cell Sci       Date:  2013-04-19       Impact factor: 5.285

8.  Human secretory immunoglobulin A may contribute to biofilm formation in the gut.

Authors:  R Randal Bollinger; Mary Lou Everett; Daniel Palestrant; Stephanie D Love; Shu S Lin; William Parker
Journal:  Immunology       Date:  2003-08       Impact factor: 7.397

Review 9.  Effect of lactoferrin on enteric pathogens.

Authors:  Theresa J Ochoa; Thomas G Cleary
Journal:  Biochimie       Date:  2008-04-18       Impact factor: 4.079

Review 10.  Specific antibody activity, glycan heterogeneity and polyreactivity contribute to the protective activity of S-IgA at mucosal surfaces.

Authors:  Jiri Mestecky; Michael W Russell
Journal:  Immunol Lett       Date:  2009-04-05       Impact factor: 3.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.